Is Lexeo Therapeutics, Inc. Common Stock overvalued?

Lexeo Therapeutics, Inc. Common Stock (LXEO) — key valuation metrics and fundamentals.

No verdict

Price

$4.84

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$380.0M

Dividend yield

0.0%

Return on equity

-47.5%

Sector

Healthcare

Fair value compares LXEO's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks